Inventor · disambiguated record
Arthur A. Vandenbark
Also filed as: VANDENBARK ARTHUR · VANDENBARK ARTHUR A
26 granted patents·14 pending applications·462 citations·filing 1993–2019
96Inventor score
Files withUNIV OREGON HEALTH & SCIENCE18BURROWS GREGORY G3OFFNER HALINA3OREGON HEALTH & SCIENCES UNIVE2ADAMUS GRAZYNA1
Top patents by PatentIndex Score
40 records- 0194US7265218B2Recombinant MHC molecules useful for manipulation of antigen-specific T-cellsUNIV OREGON HEALTH & SCIENCE·Filed 2004·Granted Sep 4, 2007·39 cites·1 claims
- 0292US6815171B2Recombinant MHC molecules useful for manipulation of antigen-specific T-cellsUNIV OREGON HEALTH & SCIENCE·Filed 2001·Granted Nov 9, 2004·39 cites·14 claims
- 0392US6270772B1Recombinant MHC molecules useful for manipulation of antigen-specific T-cellsUNIV OREGON HEALTH SCIENCES·Filed 1998·Granted Aug 7, 2001·86 cites·18 claims
- 0492US5759546ATreatment of CD4 T-cell mediated conditionsFiled 1994·Granted Jun 2, 1998·104 cites·23 claims
- 0589US7732140B2Method for direct electrical detection of molecules and molecule-molecule interactionsOREGON HEALTH & SCIENCES UNIVE·Filed 2007·Granted Jun 8, 2010·13 cites·22 claims
- 0686US8053197B2Methods for detecting and treating autoimmune disordersUNIV OREGON HEALTH & SCIENCE·Filed 2005·Granted Nov 8, 2011·6 cites·12 claims
- 0784US8491913B2Compositions and methods using recombinant MHC molecules for the treatment of strokeOFFNER HALINA·Filed 2010·Granted Jul 23, 2013·7 cites·5 claims
- 0882US8377447B2Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cellsUNIV OREGON HEALTH & SCIENCE·Filed 2004·Granted Feb 19, 2013·10 cites·19 claims
- 0982US5614192AT cell receptor peptides as therapeutics for immune-related diseaseCONNECTIVE THERAPEUTICS INC·Filed 1993·Granted Mar 25, 1997·76 cites·56 claims
- 1081US9359425B2Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addictionUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted Jun 7, 2016·3 cites·2 claims
- 1181US9050279B2Compositions and methods using recombinant MHC molecules for the treatment of strokeUNIV OREGON HEALTH & SCIENCE·Filed 2013·Granted Jun 9, 2015·2 cites·7 claims
- 1281US8895018B2Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addictionUNIV OREGON HEALTH & SCIENCE·Filed 2013·Granted Nov 25, 2014·3 cites·2 claims
- 1380US7462486B2Methods of selecting T cell receptor V peptides for therapeutic useUNIV OREGON HEALTH & SCIENCE·Filed 2003·Granted Dec 9, 2008·7 cites·14 claims
- 1474US9492536B2Compositions and methods using recombinant MHC molecules for the treatment of strokeUNIV OREGON HEALTH & SCIENCE·Filed 2015·Granted Nov 15, 2016·1 cites·14 claims
- 1574US7214528B1Device for direct electrical detection of molecules and molecule-molecule interactionsOREGON HEALTH & SCIENCES UNIVE·Filed 2002·Granted May 8, 2007·10 cites·21 claims
- 1674US6566082B1T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditionsFiled 1995·Granted May 20, 2003·32 cites·24 claims
- 1771US5776459ATCR V beta 5 peptidesCONNETICS CORP·Filed 1995·Granted Jul 7, 1998·21 cites·27 claims
- 1865US8435507B2Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancerALEXANDER RICHARD B·Filed 2005·Granted May 7, 2013·1 cites·6 claims
- 1963US9926360B2Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cellsUNIV OREGON HEALTH & SCIENCE·Filed 2015·Granted Mar 27, 2018·0 cites·12 claims
- 2062US2008064859A1Recombinant MHC molecules useful for manipulation of antigen-specific T-cellsVANDENBARK ARTHUR A·Filed 2007·Application pending·0 cites
- 2158US11945855B2Recombinant polypeptides comprising modified MHC class II DRa1 domains and methods of useUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted Apr 2, 2024·0 cites·20 claims
- 2256US9243051B2Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cellsBURROWS GREGORY G·Filed 2012·Granted Jan 26, 2016·0 cites·22 claims
- 2355US8685404B2Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addictionLOFTIS JENNIFER·Filed 2012·Granted Apr 1, 2014·1 cites·28 claims
- 2454US2008267987A1Recombinant MHC Molecules Useful For Manipulation Of Antigen-Specific T-CellsBURROWS GREGORY G·Filed 2008·Application pending·0 cites
- 2553US9260506B2Treatment of retinal disorders with recombinant T cell receptor ligand (RTL)ADAMUS GRAZYNA·Filed 2012·Granted Feb 16, 2016·1 cites·21 claims
- 2651US2011262479A1Recombinant mhc molecules useful for manipulation of antigen-specific t-cellsUS DEPT VETERANS AFFAIRS·Filed 2011·Application pending·0 cites
- 2749US10316075B2Recombinant polypeptides comprising MHC class II α1 domainsUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted Jun 11, 2019·0 cites·8 claims
- 2848US10689446B2Recombinant CD74 polypeptidesUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Jun 23, 2020·0 cites·3 claims
- 2948US10525101B2Methods of treating inflammatory or autoimmune disorders with compounds that bind macrophage migration inhibitory factorUNIV OREGON HEALTH & SCIENCE·Filed 2016·Granted Jan 7, 2020·0 cites·14 claims
- 3048US2002107388A1Methods of identifying and monitoring disease-associated T cellsFiled 2001·Application pending·0 cites
- 3148US2003007978A1Recombinant MHC molecules useful for manipulation of antigen-specific T-cellsFiled 2001·Application pending·0 cites
- 3248US2013309229A1Recombinant t cell ligands and antibodies that bind b cells for the treatment of autoimmune diseasesYANG JIANHUA·Filed 2012·Application pending·0 cites
- 3343US2016271236A1Recombinant t-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addictionUNIV OREGON HEALTH & SCIENCE·Filed 2016·Application pending·0 cites
- 3442US2018271935A1Dralpha1-mog-35-55 treatment of traumatic brain injuryOFFNER HALINA·Filed 2018·Application pending·0 cites
- 3542US2017196957A1Recombinant t cell receptor ligand compositions and methods for treatment of prostate cancerUNIV OREGON HEALTH & SCIENCE·Filed 2017·Application pending·0 cites
- 3641US2009280135A1Recombinant MHC molecules useful for manipulation of antigen-specific T-cellsOFFNER HALINA·Filed 2007·Application pending·0 cites
- 3740US2014170168A1Antibodies which bind soluble t-cell receptor ligandsREITER YORAM·Filed 2011·Application pending·0 cites
- 3837US2015044245A1Partial mhc constructs and methods of useUNIV OREGON HEALTH & SCIENCE·Filed 2013·Application pending·0 cites
- 3937US2010279401A1T Cell Hybridomas And Related Compositions And Methods For Assaying And Modulating T Cell Receptor-Mediated Immune ResponsesBURROWS GREGORY G·Filed 2005·Application pending·0 cites
- 4033US2015099706A1TREATMENT OF ISCHEMIC STROKE WITH DRa1-MOG-35-55UNIV OREGON HEALTH & SCIENCE·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Arthur A. Vandenbark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →